- Background
- What we're looking for
- What we can offer you
- Q&A
Antiperspirants, typically containing active compounds like aluminum chloride or aluminum zirconium, have raised concerns due to potential associations between aluminum exposure and health issues.
Potassium aluminum compounds present potential alternatives. Often featured in formulations promoted as natural or "aluminum-free," these compounds boast a nature-derived molecular structure, lower aluminum absorption, and reduced likelihood of causing skin irritation.
In addition to these options, presently available non-aluminum antiperspirants come with their own challenges, including allergenic botanical extracts and essential oils, formulations focusing on odor rather than sweat reduction, and undesirable textures that impact the user experience.
Current natural deodorants & aluminum-free deodorants come with consumer trade-offs, including inferior wetness and odor protection.
As the market for natural deodorancy continues to grow, we are looking for solutions in this space.
We are looking for technologies and formulations that provide wetness reduction and thus can serve as alternative antiperspirants. We are a consumer products company seeking partnerships from outside companies and experts.
- Deodorant products of interest include the following: Sprays, sticks, creams, gels, or other forms directly applied to skin.
- Technologies can be integrated in a deodorant product.
- Formulations and/or technologies that are alternatives to aluminum chloride and aluminum zirconium that provide a wetness reduction benefit.
- Solution can be applied as a topical formulation.
- Solutions should have technical data showing evidence of sweat reduction via a scientific study.
- Solutions should be non-toxic and should not damage skin.
- The ideal solution would be a finished formulation that demonstrates sweat reduction. We are also interested in co-development for materials/ technologies that show proof-of-concept for wetness protection. Partners with research or technologies relevant to sweat reduction are encouraged to apply.
- Compliant with US and Canada regulations (and international equivalents) through 2030
- Antiperspirant active compounds cited on US FDA Monograph M019: Antiperspirant Drug Products for Over-the-Counter Human Use are out of scope. (The exception is formulations containing potassium alum)
- Industry-standard, commodity or common in-market solutions (products that do not resolve major tradeoffs of Al-free products today)
- Textiles
- Ingestibles
The Q&A is now closed.
Other recommended requests
delivered to your inbox.